Geospatial clustering and modelling provide policy guidance to distribute funding for active TB case finding in Ethiopia.

Active TB case finding Cost-effectiveness analysis Geospatial clustering Mathematical modelling Tuberculosis

Journal

Epidemics
ISSN: 1878-0067
Titre abrégé: Epidemics
Pays: Netherlands
ID NLM: 101484711

Informations de publication

Date de publication:
09 2021
Historique:
received: 22 07 2019
revised: 27 01 2020
accepted: 17 05 2021
pubmed: 31 5 2021
medline: 26 10 2021
entrez: 30 5 2021
Statut: ppublish

Résumé

Tuberculosis (TB) exhibits considerable spatial heterogeneity, occurring in clusters that may act as hubs of community transmission. We evaluated the impact of an intervention targeting spatial TB hotspots in a rural region of Ethiopia. To evaluate the impact of targeted active case finding (ACF), we used a spatially structured mathematical model that has previously been described. From model equilibrium, we simulated the impact of a hotspot-targeted strategy (HTS) on TB incidence ten years from intervention commencement and the associated cost-effectiveness. HTS was also compared with an untargeted strategy (UTS). We used logistic cost-coverage analysis to estimate cost-effectiveness of interventions. At a community screening coverage level of 95 % in a hotspot region, which corresponds to screening 20 % of the total population, HTS would reduce overall TB incidence by 52 % compared with baseline. For UTS to achieve an equivalent effect, it would be necessary to screen more than 80 % of the total population. Compared to the existing passive case detection strategy, the HTS at a CDR of 75 percent in hotspot regions is expected to avert 1,023 new TB cases over ten years saving USD 170 per averted case. Similarly, at the same CDR, the UTS will detect 1316 cases over the same period saving USD 3 per averted TB case. The incremental-cost effectiveness-ratio (ICER) of UTS compared with HTS is USD 582 per averted case corresponding to 293 more TB cases averted at an additional cost of USD 170,700. Where regional TB program spending was capped at current levels, maximum gains in incidence reduction were seen when the regional budget was shared between hotspots and non-hotspot regions in the ratio of 40% : 60%. Our analysis suggests that a spatially targeted strategy is efficient and cost-saving, with the potential for significant reduction in overall TB burden.

Identifiants

pubmed: 34052666
pii: S1755-4365(21)00027-X
doi: 10.1016/j.epidem.2021.100470
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

100470

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.

Auteurs

Debebe Shaweno (D)

Department of Medicine, University of Melbourne, 300 Grattan Street, Melbourne, Victoria, 3050, Australia; Victorian Tuberculosis Program at the Peter Doherty Institute for Infection and Immunity, 792 Elizabeth Street, Melbourne, 3000, Victoria, Australia; Department of Health Economics and Decision Science, School of Health and Related Research, The University of Sheffield, 30 Regent Street, Sheffield, S1 4DA, United Kingdom. Electronic address: d.shaweno@sheffield.ac.uk.

James M Trauer (JM)

Victorian Tuberculosis Program at the Peter Doherty Institute for Infection and Immunity, 792 Elizabeth Street, Melbourne, 3000, Victoria, Australia; School of Public Health and Preventive Medicine, Monash University, 553 St Kilda Rd, Melbourne, Victoria, 3004, Australia.

Tan N Doan (TN)

Department of Medicine, University of Melbourne, 300 Grattan Street, Melbourne, Victoria, 3050, Australia; Australian Institute of Tropical Health and Medicine, James Cook University, Douglas, Townsville, QLD, 4814, Australia.

Justin T Denholm (JT)

Victorian Tuberculosis Program at the Peter Doherty Institute for Infection and Immunity, 792 Elizabeth Street, Melbourne, 3000, Victoria, Australia; Department of Microbiology and Immunology, University of Melbourne792 Elizabeth Street, Melbourne, 3000, Victoria, Australia.

Emma S McBryde (ES)

Department of Medicine, University of Melbourne, 300 Grattan Street, Melbourne, Victoria, 3050, Australia; Australian Institute of Tropical Health and Medicine, James Cook University, Douglas, Townsville, QLD, 4814, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH